Data is not held on the exact median waiting time to diagnosis for suspected sarcoma from general practice referral. Data is published on the time from referral to diagnosis for suspected sarcoma, by time bands, at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/monthly-data-and-summaries/

The following table shows the number of suspected sarcoma diagnoses, or cancer being ruled out, sorted by time band, in May 2026 for England:

As part of the 2026/27 GP Contract, we are embedding the current Advice and Guidance (A&G) enhanced service funding within core practice funding. Practices will be required to use A&G prior to or in place of a planned care referral, where clinically appropriate, and to follow locally agreed referral pathways.

A&G has shown clear value in supporting timely specialist input, reducing unnecessary referrals, and ensuring patients receive timely care in the most appropriate setting.

Between April 2025 and December 2025, A&G has avoided 1.3 million patients being added to waiting lists.

All registered doctors in the United Kingdom are expected to meet the professional standards set by the General Medical Council (GMC). In 2012, the GMC introduced revalidation, which supports doctors in regularly reflecting on how they can develop or improve their practice.

General practitioners (GPs) are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high quality care to all patients.

The training curricula for postgraduate trainee doctors is set by the Royal College of General Practitioners (RCGP) and has to meet the standards set by the GMC. The RCGP provides several resources on cancer prevention, diagnosis, and care for GPs, relevant for the primary care setting.

We are investing an additional £1.1 billion in GPs to reinforce the front door of the National Health Service, bringing total spend on the GP Contract to £13.4 billion in 2025/26, the biggest increase in over a decade. The 8.9% boost to the GP Contract in 2025/26 is bigger than the 5.8% growth to the NHS budget as a whole, demonstrating our commitment to shifting resources to the community.

The Department is committed to getting the National Health Service diagnosing cancer earlier and treating it faster to improve survival rates, including for children and young people. To achieve this, the NHS has delivered an extra 40,000 operations, scans, and appointments each week as the first step to ensuring early diagnosis and faster treatment.

General practitioners (GPs) are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development.

All registered doctors in the United Kingdom are also expected to meet the professional standards set by the General Medical Council (GMC). In 2012, the GMC introduced revalidation, which supports doctors in regularly reflecting on how they can develop or improve their practice.

The training curricula for postgraduate trainee doctors is set by the Royal College of General Practitioners (RCGP) and has to meet the standards set by the GMC. The RCGP provides several resources on cancer prevention, diagnosis, and care for GPs, relevant for the primary care setting.

On 4 February 2025, the Department relaunched the Children and Young People Cancer Taskforce to identify tangible ways to improve outcomes and experiences for children and young people with cancer. The taskforce is exploring opportunities for improvement across genomic testing and treatment, research and innovation, patient experience, and early detection and diagnosis.

The forthcoming National Cancer Plan will include further details on improving outcomes for cancer patients, including for children and young people with cancer, and will highlight how the Department will support the NHS to improve diagnosis rates for people in all parts of England.

The training curriculum for postgraduate trainee general practitioners (GPs) is set by the Royal College of General Practitioners and has to meet the standards set by the General Medical Council. Additionally, GPs are responsible for ensuring their own clinical knowledge, including on cancer, remains up-to-date, and for identifying learning needs as part of their continuing professional development.

NHS England funds delivery of GatewayC, the leading online early cancer diagnosis e-training resource for GPs and primary care staff. Where relevant, e-learning courses contain a risk factors section, and in the current update of the existing Lung Cancer course, GatewayC has added welding fumes to the risk factor card on 'chemicals and workplace risk'. From the Health and Safety Executive’s guidance, the increased risk is primarily for lung cancer, but there is also some evidence of an increased risk of kidney cancer. The upcoming Urological Cancers course doesn't directly refer to this but has a cover-all statement on workplace risk, stating: 'exposure to certain chemicals at work may increase the risk of bladder and kidney cancer'.

NHS England has also significantly expanded the Lung Cancer Screening Programme, formerly known as the Targeted Lung Health Check. The programme currently operates across more than a quarter of England, prioritising areas with the highest lung cancer mortality and levels of deprivation. Mobile scanning units in community settings, such as supermarket car parks, have helped to improve access and uptake. The programme is on track to offer screening nationally by 2029, with a target to invite at least 50% of the eligible population by March 2026.

The Government is supporting NHS England to ensure that information on diagnoses and treatment, including cancer test results, are shared between services routinely and in a timely manner.

NHS England has been supporting National Health Service trusts and foundation trusts in acquiring and developing the effectiveness of their electronic patient records, and support is available to bring trusts to an optimum level of digital maturity which will further reduce barriers to the sharing of information needed to treat patients. Further information can be found at the following link:

https://www.england.nhs.uk/long-read/data-and-clinical-record-sharing/

The Department supported the NHS’s Connecting Care Records programme which joins up information based on the individual rather than through one organisation. Through targeted investment, local Connecting Care Record systems have been established in all integrated commissioning board areas. 97% of trusts and 92% of primary care networks are now connected, in order to share information such as medications, allergies, test results, and clinical correspondence.

Furthermore, my Rt Hon. Friend, the Secretary of State for Health and Social Care has announced the intention for there to be a single patient record which would provide a comprehensive patient record, reducing duplication when patients have to repeat their medical history when interacting with the NHS.

It is a priority for the Government to support the National Health Service to diagnose cancer, including rare and less common cancers, earlier, in order to improve outcomes, including survival rates.

We are streamlining referral routes and increasing the availability of diagnostic capacity through the roll-out of more community diagnostic centres. Additionally, we are streamlining referral routes through the implementation of a non-specific symptom pathway, for patients who present with vague and non-site-specific symptoms which do not clearly align to a tumour type.

We are also investing an additional £889 million in general practices (GPs) to reinforce the front door of the NHS, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This is the biggest increase in over a decade.

The National Cancer Plan, which will complement the 10-Year Health Plan and support delivery of the Government’s Health Mission, will set out further actions to improve early diagnosis, including GP referral for suspected cancer. The plan will also consider how we can better identify and monitor people at increased risk of developing cancer.

General practitioners (GPs) are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development.

All United Kingdom registered doctors are also expected to meet the professional standards set by the General Medical Council (GMC). In 2012, the GMC introduced revalidation, which supports doctors in regularly reflecting on how they can develop or improve their practice.

The training curricula for postgraduate trainee doctors is set by the Royal College of General Practitioners (RCGP), and has to meet the standards set by the GMC. The RCGP provides a number of resources on cancer prevention, diagnosis, and care for GPs, relevant for the primary care setting.

Improving diagnosis rates and access to treatment are key priorities for the Government for all cancer types, including rare and less common cancers.

We are improving public awareness of cancer signs and symptoms, streamlining referral routes, and increasing the availability of diagnostic capacity through the roll-out of more community diagnostic centres. We are also investing an additional £889 million in GPs to reinforce the front door of the National Health Service, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This is the biggest increase in over a decade.

We are committed to ensuring that GPs have the right training and systems to identify cancer. Use of specific clinical decision support tools are agreed at a local level.

The recently announced National Cancer Plan, which will complement the 10-Year Health Plan and support delivery of the Government’s Health Mission, will set out further actions to improve diagnosis, including for rare and less common cancers. The plan will also provide further details on how we will ensure patients have access to the latest treatments and technology, ultimately bringing this country’s cancer survival rates back up to the standards of the best in the world.